Author

Ian Rose

Vaccine and Gene Therapy Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

Dylan T. BoehmiD· 2 shared Jinu AbrahamiD· 2 shared Kevin Jimenez-Perez· 2 shared Laura SpringgayiD· 2 shared Nobuyo MizunoiD· 2 shared Victor R. DeFilippis· 2 shared Ahmad Junaid· 1 shared D.A. Burkhart· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Dylan T. BoehmORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Characterization of a Novel Transmembrane Activating STING Agonist using Genetically Humanized Mice

Nobuyo Mizuno, Jinu Abraham, Kevin Jimenez-Perez, Ian Rose, Laura Springgay, Dylan T. Boehm, Takeshi Ando, Daniel N. Streblow, Janine M. Ward, Shannon M. Miller, Uddav Pandey, Ahmad Junaid, David Joyner, Roshell Muir, Elias K. Haddad, , Victor R. DeFilippis

This study develops a novel transmembrane STING agonist and validates its efficacy in genetically humanized mice, showing enhanced immune and antitumor responses.

Cell Reports · Jun 1, 2026Peer-reviewedImmunology

Comparative Molecular, Innate, and Adaptive Impacts of Chemically Diverse STING Agonists

Nobuyo Mizuno, Dylan T. Boehm, Kevin Jimenez-Perez, Jinu Abraham, Laura Springgay, Ian Rose, Victor R. DeFilippis

This study compares molecular and immune responses to diverse STING agonists to identify differences in potency and immune outcomes.

Vaccine · Jun 13, 2025Peer-reviewedImmunology